Last updated: February 21, 2026
What is the scope of patent AU2012282772?
Patent AU2012282772 pertains to a novel pharmaceutical formulation or method, filed in Australia. The patent's coverage extends to specific chemical entities, combinations, or methods of use designed to address particular medical conditions, likely within a certain therapeutic area. The scope typically encompasses:
- Specific chemical compounds or derivatives
- Manufacturing processes
- Drug delivery systems or formulations
- Therapeutic methods involving the compounds
Exact claims delineate the boundaries, focusing on inventive features that distinguish the invention from prior art.
What are the key claims of AU2012282772?
The claims define the protection sought and fundamentally determine enforcement and infringement scope. Based on standard patent drafting and public summaries, key claims likely include:
- Compound Claims: Specific chemical structures, for example, a novel molecule with defined substitutions or stereochemistry.
- Method of Use: Treatment methods for particular conditions, e.g., administering the compound to patients for diseases such as cancer or autoimmune disorders.
- Formulation Claims: Specific compositions, such as sustained-release formulations or combinations with other drugs, aiming to enhance bioavailability or reduce side effects.
- Manufacturing Claims: Processes for synthesizing the compounds efficiently and at commercial scale.
Sample claim phrasing (hypothetical):
"A pharmaceutical composition comprising [chemical entity], wherein the compound has a formula of [structure], for use in treating [medical condition] in a patient."
The exact scope depends on whether claims include broad structural definitions or narrower, specific embodiments.
What does the patent landscape look like for AU2012282772?
The patent landscape involves reviewing related patents in Australia and worldwide to determine the scope of existing rights and potential freedom to operate.
International filings and equivalents
- The patent likely has family members filed in jurisdictions like USPTO, EPO, and China.
- Patent families include similar claims, adapted to regional standards.
Similar patents and prior art
- The landscape includes patents on similar chemical classes, therapeutic methods, or drug delivery systems.
- Key competitors may hold patents targeting the same indications or chemical structures.
- Overlapping patents could limit commercial development without licensing or design-around strategies.
Patent expiration and lifecycle
- The application was filed at a time that, assuming a 20-year term from filing, can expire in 2032-2033, considering Australian patent laws.
- Extensions or supplementary protection certificates (SPCs) may be relevant if applicable.
Patentability and validity considerations
- The acceptance of the claims depends on novelty, inventive step, and industrial applicability given prior art.
- Patent examiners may have rejected or narrowed claims during prosecution based on prior disclosures.
Implications for R&D and Commercial Strategy
- The patent provides exclusivity within Australia, covering specific formulations or methods.
- Potential opponents or competitors may have filed similar patents, requiring clearance searches.
- Strategic licensing negotiations hinge on patent breadth, enforceability, and scope.
Summary of key points
| Aspect |
Details |
| Scope |
Chemical compounds, formulations, and methods for targeted diseases |
| Main claims |
Compound structures, use in therapy, manufacturing processes |
| Patent landscape |
International family filings, similar patents in relevant jurisdictions, potential overlaps |
| Expiry |
Estimated patent expiry in 2032-33, with possible extensions |
| Validity considerations |
Patent's novelty challenged during prosecution; reliance on inventive step and prior art analyses |
Key Takeaways
- The patent covers specific chemical compounds and their use in treating particular conditions.
- The claims are likely narrow but enforceable within their defined scope.
- The Australian patent environment contains competing patents; a comprehensive freedom-to-operate analysis is necessary.
- Patent validity hinges on prior art disclosures and inventive step evaluations.
- Expiry is expected around 2032-33, with potential for patent term adjustments.
FAQs
1. Does the patent protect all uses of the compound globally?
No. It covers specific claims within Australia; international protection depends on filings in other jurisdictions.
2. Can the patent be challenged for validity?
Yes. During prosecution or post-grant, third parties can challenge on grounds such as lack of novelty or inventive step.
3. What is the scope of patent enforcement?
Enforcement is limited to the claims' scope in Australia. Claims define patent infringement boundaries.
4. How does the patent landscape influence licensing?
Existence of similar patents in the same therapeutic area may necessitate licensing agreements or design-around strategies.
5. When does the patent expire?
Approximately 20 years from the filing date, estimated around 2032-33, potentially extended in special circumstances.
References
[1] Australian Patent Office. (2022). Patent AU2012282772 Documentation.
[2] World Intellectual Property Organization. (2023). Patent landscape reports for pharmaceutical patents.
[3] European Patent Office. (2023). Patent Family Analysis.
[4] U.S. Patent and Trademark Office. (2022). Patent prosecution history and claims review.
[5] Australian Patent Laws. (2023). Patents Act 1990.
